Skip to main content
Peter Lucas, MD, Pathology, Pittsburgh, PA, UPMC Presbyterian Shadyside

PeterCLucasMDPhD

Pathology Pittsburgh, PA

Molecular Genetics, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor, University of Pittsburgh School of Medicine/UPMC; Director of Pathology, NSABP division of NRG Oncology

Dr. Lucas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lucas' full profile

Already have an account?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemResidency, Pathology-Anatomic and Clinical, 1996 - 2001
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1996
  • Vanderbilt University
    Vanderbilt UniversityPhD, 1992

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2012 - 2024
  • MN State Medical License
    MN State Medical License 2023 - 2024
  • MI State Medical License
    MI State Medical License 1999 - 2015
  • American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

Press Mentions

  • How High Fat Foods Impact Diabetes and Metabolic Syndrome
    How High Fat Foods Impact Diabetes and Metabolic SyndromeMay 22nd, 2012

Grant Support

  • GPCR signaling through a novel NF-kB pathwayNational Heart, Lung, and Blood Institute (NHLBI)2013–2018
  • Angiotensin II Signaling Through A Novel Nf-Kb PathwayNational Heart, Lung, And Blood Institute2008–2012
  • Novel Signal Pathway Mediating Hypertension/Obesity-Dependent Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2011
  • A Novel Signaling Pathway Mediating Hypertension- And Obesity-Dependent Insulin RNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
  • Nf-Kb Signaling &Molec Pathogenesis Of MALT LymphomaNational Cancer Institute2002–2006
  • Ciper--A Novel Apoptosis Regulator Involved In CancerNational Cancer Institute2000–2002

Hospital Affiliations